Novartis Unifies Oncology, Transplantation & Ophthalmics Under Epstein
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis' has unified oncology, transplantation and ophthalmics into one specialty medicine business unit as the company's product mix shifts more toward specialty care